Terumo Corp 2023 IR
The report outlines Terumo Group's financial and sustainability performance for fiscal 2022, highlighting record-high sales revenue of 820.2 billion yen. Key achievements include a 21.7% reduction in Scope 1 and 2 greenhouse gas emissions compared to fiscal 2018 and increasing the renewable energy use ratio to 32.1%. The company established a new Sustainability Committee chaired by the President and CEO to monitor CSV and ESG initiatives. Additionally, Terumo expanded its global leadership programs and advanced its transradial intervention procedures to improve patient quality of life and medical cost efficiency.
Company: Terumo Corp
Sector: Health Care
Country: Japan
Year: 2023
Type: IR
Pages: 104
Terumo Corp
Terumo Report
The report outlines Terumo Group's financial and sustainability performance for fiscal 2022, highlighting record-high sales revenue of 820.2 billion yen. Key achievements include a 21.7% reduction in Scope 1 and 2 greenhouse gas emissions compared to fiscal 2018 and increasing the renewable energy use ratio to 32.1%. The company established a new Sustainability Committee chaired by the President and CEO to monitor CSV and ESG initiatives. Additionally, Terumo expanded its global leadership programs and advanced its transradial intervention procedures to improve patient quality of life and medical cost efficiency.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2023
Reporting Period
Apr 1, 2022 - Mar 31, 2023
Fiscal Year
2022
Type
Integrated Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Assurance
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
No data available